SLC6A3 and frontotemporal dementia: We found that dopamine transporter levels were reduced in frontotemporal dementia compared to healthy controls (P < 0.001) and that frontotemporal dementia showed a higher putamen-to-caudate ratio than Parkinson’s disease (P < 0.001), particularly notable in patients with identified disease-causing mutation.